Gris-PEG (Pedinol Pharmacal, Inc.)
Welcome to the PulseAid listing for the Gris-PEG drug offered from Pedinol Pharmacal, Inc.. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pedinol Pharmacal, Inc. |
NON-PROPRIETARY NAME: | griseofulvin |
SUBSTANCE NAME: | GRISEOFULVIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-07-26 |
END MARKETING DATE: | 0000-00-00 |
Gris-PEG HUMAN PRESCRIPTION DRUG Details:
Item Description | Gris-PEG from Pedinol Pharmacal, Inc. |
LABELER NAME: | Pedinol Pharmacal, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 125(mg/1) |
START MARKETING DATE: | 2016-07-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0884-0763_d3d67926-0727-496e-b54c-d6c8770f84d6 |
PRODUCT NDC: | 0884-0763 |
APPLICATION NUMBER: | NDA050475 |
Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers: